Source: Virtual Congress 2020 – Pulmonary vascular diseases
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Humbert (Le Kremlin-Bicêtre, France). Novel insights into the pathogenesis of pulmonary arterial hypertension. Virtual Congress 2020 – Pulmonary vascular diseases

Member's Comments

No comment yet.

Related content which might interest you: New insights in pulmonary vascular biology and pathophysiology Source: Annual Congress 2006 - Physiological year in review Year: 2006 Novel therapeutic perspectives in pulmonary arterial hypertension Source: Eur Respir J 2003; 22: 193-194 Year: 2003 Novel techniques for advancing our understanding of pulmonary arterial hypertension Source: Eur Respir J, 53 (5) 1900556; 10.1183/13993003.00556-2019 Year: 2019 Novel biomarkers in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension Source: Eur Respir J, 58 (5) 2000653; 10.1183/13993003.00653-2020 Year: 2021 The genetics of pulmonary arterial hypertension Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005 Novel treatment for pulmonary vascular disease: lessons from pathophysiology Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms Source: Eur Respir Rev, 30 (160) 200284; 10.1183/16000617.0284-2020 Year: 2021 CFTR involvement in the pathogenesis of pulmonary arterial hypertension Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology Source: Eur Respir Rev 2009; 19: 59-63 Year: 2010 Introduction: overview of pulmonary arterial hypertension pathogenesis Source: International Congress 2016 – Pulmonary arterial hypertension: future therapeutic approaches Year: 2016 Towards a molecular classification of pulmonary arterial hypertension Source: Eur Respir J 2016; 48: 987-989 Year: 2016 Gaining insights into pulmonary hypertension in respiratory diseases Source: Eur Respir J 2015; 46: 1247-1250 Year: 2015 Exercise pathophysiology in patients with pulmonary arterial hypertension Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease Year: 2007 Partitioning of pulmonary vascular resistances in group 2 pulmonary hypertension: insightful suggestions for bridging haemodynamics to underlying mechanisms Source: Eur Respir J, 51 (5) 1800816; 10.1183/13993003.00816-2018 Year: 2018 Cellular microparticles in the pathogenesis of pulmonary hypertension Source: Eur Respir J 2013; 42: 272-279 Year: 2013 Endothelial NO and its pathophysiologic regulation Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease Year: 2007 Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with BMPR2 mutation Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Pathogenesis of pulmonary arterial hypertension: lessons from cancer Source: Eur Respir Rev 2013; 22: 543-551 Year: 2013